Geoffrey Teixeira

739 total citations
15 papers, 637 citations indexed

About

Geoffrey Teixeira is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Geoffrey Teixeira has authored 15 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pathology and Forensic Medicine and 3 papers in Surgery. Recurrent topics in Geoffrey Teixeira's work include Cardiac Ischemia and Reperfusion (5 papers), Mitochondrial Function and Pathology (3 papers) and ATP Synthase and ATPases Research (2 papers). Geoffrey Teixeira is often cited by papers focused on Cardiac Ischemia and Reperfusion (5 papers), Mitochondrial Function and Pathology (3 papers) and ATP Synthase and ATPases Research (2 papers). Geoffrey Teixeira collaborates with scholars based in France, Switzerland and Brazil. Geoffrey Teixeira's co-authors include Michel Ovize, Ludovic Gomez, M. Paillard, Maryline Abrial, Alain Lacampagne, Jérémy Fauconnier, Jennifer Rieusset, Emily Tubbs, Annie Durand and Claire Crola Da Silva and has published in prestigious journals such as Circulation, Cancer Research and Journal of the American Society of Nephrology.

In The Last Decade

Geoffrey Teixeira

14 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geoffrey Teixeira France 9 448 159 132 122 107 15 637
Marcos Poncelas Spain 12 243 0.5× 103 0.6× 205 1.6× 60 0.5× 156 1.5× 14 509
Michel Ovize France 13 241 0.5× 43 0.3× 198 1.5× 86 0.7× 110 1.0× 18 514
Pierre‐Alain Thiébaut France 8 341 0.8× 125 0.8× 71 0.5× 106 0.9× 58 0.5× 13 513
Evelyn M. Kanter United States 16 489 1.1× 50 0.3× 99 0.8× 30 0.2× 403 3.8× 25 769
Yehia Marreez United States 8 541 1.2× 137 0.9× 62 0.5× 98 0.8× 279 2.6× 8 695
Xiaoding Wang China 12 316 0.7× 193 1.2× 40 0.3× 164 1.3× 127 1.2× 16 700
Víctor Hernando Spain 15 404 0.9× 199 1.3× 511 3.9× 63 0.5× 277 2.6× 16 913
Vassily I. Kutyavin United States 7 264 0.6× 97 0.6× 68 0.5× 72 0.6× 115 1.1× 10 552
Maki Katamura Japan 8 216 0.5× 22 0.1× 131 1.0× 126 1.0× 170 1.6× 12 533
Dehuang Guo United States 12 268 0.6× 35 0.2× 68 0.5× 48 0.4× 79 0.7× 17 531

Countries citing papers authored by Geoffrey Teixeira

Since Specialization
Citations

This map shows the geographic impact of Geoffrey Teixeira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey Teixeira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey Teixeira more than expected).

Fields of papers citing papers by Geoffrey Teixeira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffrey Teixeira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey Teixeira. The network helps show where Geoffrey Teixeira may publish in the future.

Co-authorship network of co-authors of Geoffrey Teixeira

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffrey Teixeira. A scholar is included among the top collaborators of Geoffrey Teixeira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffrey Teixeira. Geoffrey Teixeira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Jensen, Ditte Marie, Michael Christensen, Geoffrey Teixeira, et al.. (2025). Deep learning‐enhanced 3D imaging unveils semaglutide impact on cardiac fibrosis. British Journal of Pharmacology. 183(5). 1030–1047. 1 indexed citations
2.
Delbet, Jean‐Daniel, Vincent Anquetil, Alberto Toso, et al.. (2024). #2837 Novel therapeutic for crescentic glomerulonephritis through targeting CLDN1 in parietal epithelial cells. Nephrology Dialysis Transplantation. 39(Supplement_1). 1 indexed citations
3.
Toso, Alberto, Geoffrey Teixeira, Daniela Schmitter, et al.. (2023). Abstract LB284: CLAUDIN-1 targeting antibody ALE.C04 drives single activity and restores anti-PD1 efficacy in solid tumors. Cancer Research. 83(8_Supplement). LB284–LB284. 1 indexed citations
4.
Teixeira, Geoffrey, Jean‐Daniel Delbet, Vincent Anquetil, et al.. (2023). Claudin-1 Is a Therapeutic Target for Crescentic Glomerulonephritis. Journal of the American Society of Nephrology. 34(11S). 238–238. 2 indexed citations
5.
Mazelin, Laetitia, Baptiste Panthu, Anne-Sophie Nicot, et al.. (2016). mTOR inactivation in myocardium from infant mice rapidly leads to dilated cardiomyopathy due to translation defects and p53/JNK-mediated apoptosis. Journal of Molecular and Cellular Cardiology. 97. 213–225. 40 indexed citations
6.
Rieusset, Jennifer, Jérémy Fauconnier, M. Paillard, et al.. (2015). Disruption of calcium transfer from ER to mitochondria links alterations of mitochondria-associated ER membrane integrity to hepatic insulin resistance. Diabetologia. 59(3). 614–623. 142 indexed citations
7.
Teixeira, Geoffrey, Pascal Chiari, Jérémy Fauconnier, et al.. (2015). Involvement of Cyclophilin D and Calcium in Isoflurane-induced Preconditioning. Anesthesiology. 123(6). 1374–1384. 13 indexed citations
8.
Abrial, Maryline, Claire Crola Da Silva, Bruno Pillot, et al.. (2014). Cardiac fibroblasts protect cardiomyocytes against lethal ischemia–reperfusion injury. Journal of Molecular and Cellular Cardiology. 68. 56–65. 67 indexed citations
9.
Paillard, M., Emily Tubbs, Pierre‐Alain Thiébaut, et al.. (2013). Depressing Mitochondria-Reticulum Interactions Protects Cardiomyocytes From Lethal Hypoxia-Reoxygenation Injury. Circulation. 128(14). 1555–1565. 227 indexed citations
10.
Chiari, Pascal, Geoffrey Teixeira, Elisabeth Couture-Lepetit, et al.. (2013). Cyclosporine A at reperfusion fails to reduce infarct size in the in vivo rat heart. Basic Research in Cardiology. 108(5). 379–379. 29 indexed citations
11.
Teixeira, Geoffrey, Maryline Abrial, Karine Portier, et al.. (2012). Synergistic protective effect of cyclosporin A and rotenone against hypoxia–reoxygenation in cardiomyocytes. Journal of Molecular and Cellular Cardiology. 56. 55–62. 33 indexed citations
12.
Teixeira, Geoffrey, Hugo P. Monteiro, Edna Frasson de Souza Montero, et al.. (2012). Atenolol to Treat Intestinal Ischemia and Reperfusion in Rats. Transplantation Proceedings. 44(8). 2313–2316. 8 indexed citations
13.
Gomez, Ludovic, M. Paillard, Megan M. Price, et al.. (2011). A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection. Basic Research in Cardiology. 106(6). 1341–1353. 65 indexed citations
14.
Teixeira, Geoffrey, et al.. (1977). Treatment of South American Blastomycosis (Paracoccidioidomycosis) with Miconazole by the Oral Route: An On-going Study. Proceedings of the Royal Society of Medicine. 70(1_suppl). 35–39. 6 indexed citations
15.
Teixeira, Geoffrey, et al.. (1969). [Experimental South American blastomycosis in the rat. Development of the experimental disease in animals infected with Yoshida sarcoma].. PubMed. 75(2). 505–10. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026